{"prompt": "['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 12 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', 'ABBREVIATIONS', 'ADR(s)', 'Adverse Drug Reaction(s)', 'AE', 'Adverse Event', 'AESI', 'Adverse Event of Special Interest', 'ALAT', 'Latin American Thoracic Association', 'ALT', 'Alanine Aminotransferase', 'ANCOVA', 'Analysis of Covariance', 'AST', 'Aspartate Aminotransferase', 'ATP', 'Adenosine Triphosphate', 'ATS', 'American Thoracic Society', 'b.i.d./BID', 'bis in die (twice daily dosing)', 'BHCG', 'Beta Human Chorionic Gonadotrophin', 'CA', 'Competent Authority', 'COPD', 'Chronic Obstructive Pulmonary Disease', 'CRA', 'Clinical Research Associate', 'CRF', 'Case Report Form, paper or electronic (sometimes referred to as \"eCRF\")', 'CTCAE', 'Common Terminology Criteria for Adverse Events', 'CTL', 'Clinical Trial Leader', 'CTM', 'Clinical Trial Manager', 'CWRCE', 'Constant Work Rate Cycle Ergometry', 'DILI', 'Drug Induced Liver Injury', 'DLco', 'Carbon Monoxide Diffusion Capacity', 'DOMS', 'Delayed Onset Muscle Soreness', 'D-PPAC', 'Daily Assessment of Physical Activity', 'd/t', 'Velocity (distance/time)', 'ECG', 'Electrocardiogram', 'EDC/eDC', 'Electronic Data Capture', 'eDiary', 'Electronic Diary/Electronic Interface', 'EELV', 'End-Expiratory Lung Volume', 'EOT', 'End of Treatment', 'ERS', 'European Respiratory Society', 'EudraCT', 'European Clinical Trials Database', 'f', 'Breathing Frequency', 'FC', 'Flow Chart', 'FDA', 'Food and Drug Administration', 'FGF/R', 'Fibroblast Growth Factor/Receptor', 'FLT3', 'Fms-like Tyrosine Kinase-3', 'FVC', 'Forced Vital Capacity', 'GCP', 'Good Clinical Practice', 'Hgb', 'Hemoglobin', 'HR', 'Heart Rate', 'HRQoL', 'Health Related Quality of Life', 'HRCT', 'High Resolution Computed Tomography', 'IC', 'Inspiratory Capacity', '01-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 13 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', 'ICH', 'International Council on Harmonization', 'IEC', 'Independent Ethics Committee', 'ILD', 'Interstitial Lung Disease', 'IPF', 'Idiopathic Pulmonary Fibrosis', 'IRB', 'Institutional Review Board', 'IRT', 'Interactive Response Technology', 'ISF', 'Investigator Site File', 'JRS', 'Japanese Respiratory Society', 'KBILD', \"King's Brief ILD Questionnaire\", 'LDH', 'Lactic Acid Dehydrogenase', 'LPDD', 'Last Patient Drug Discontinuation', 'MAH', 'Marketing Authorization Holder', 'MedDRA', 'Medical Dictionary for Drug Regulatory Activities', 'NAC', 'N-Acetyl Cystine', 'nRTKs', 'Non-receptor Tyrosine Kinases', 'OPU', 'Operating Unit', 'PDGF/R', 'Platelet Derived Growth Factor/Receptor', 'PR', 'Pulmonary Rehabilitation', 'QLF', 'Quantitative Lung Fibrosis Score', 'QoL', 'Quality of Life', 'REML', 'Restricted Maximum Likelihood2', 'RS', 'Randomized Set', 'RTKs', 'Receptor Tyrosine Kinases', 'SADR(s)', 'Serious Adverse Drug Reaction(s)', 'SAE', 'Serious Adverse Event', 'SaO2', 'Oxygen Saturation', 'SD', 'Standard Deviation', 'SOP(s)', 'Standard Operating Procedure(s)', 'SPO2', 'Blood Oxygen Saturation or peripheral capillary oxygen saturation', 'Te', 'Expiration Time', 'Ti', 'Inspiration Time', 'TLC', 'Total Lung Capacity', 'TSAP', 'Trial Statistical Analysis Plan', 'UCSD SOBQ', 'University of California San Diego Shortness of Breath Questionnaire', 'ULN', 'Upper Limit of Normal', 'US', 'United States', 'VE', 'Minute Ventilation', 'VEGF/R', 'Vascular Endothelial Growth Factor/Receptor', 'VCO2', 'Carbon Dioxide Production', 'VMU', 'Vector Magnitude Units per Minute', 'VO2', 'Oxygen Consumption', 'VT', 'Tidal Volume', 'Wcap', 'Maximal Work Capacity', 'WHO', 'World Health Organization', 'WOCBP', 'Woman of childbearing potential', '6MWD', 'Six Minute Walk Distance', '01-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']\n\n###\n\n", "completion": "END"}